Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Genital Herpes Market?

The market for genital herpes has witnessed robust expansion in the last few years. The market size, which stood at $2.19 billion in 2024, is projected to escalate to $2.34 billion in 2025, depicting a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period is a result of factors such as improved awareness and diagnostic measures, advancements in therapeutic approaches, enhanced healthcare accessibility, public health promotion campaigns, and changing socio-demographic factors.

Expectations are that the genital herpes market will experience significant expansion in the upcoming years. With a compound annual growth rate (CAGR) of 6.4%, it is projected to reach $2.99 billion by 2029. This forecasted growth can be traced back to factors such as increased education and awareness, breakthroughs in treatments and vaccines, a rise in incidence rates, advancements in digital health technology, broader access to healthcare, and the proliferation of awareness programs about sexually transmitted infections (STIs). The forecast period also indicates key trends including the adoption of telemedicine, progress in antiviral therapies, extensive research and development in vaccines, improving access to healthcare, heightened public awareness drives, and the incorporation of artificial intelligence and data analysis.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Genital Herpes Market?

The heightened attention towards sexual health is anticipated to accelerate the expansion of the genital herpes market. This attention is due to the growing realization of its crucial impact on overall health and life quality. Services for sexual health to aid genital herpes entail diagnosis, treatment, advice, and continuous supervision to assist individuals in handling flare-ups, halting transmission, and dealing with emotional and relationship matters tied to this condition. For instance, in January 2024, as per the Local Government Association, a national membership organization based in the UK, the need for sexual health services spiked, with approximately 4.5 million discussions held in 2022, recording a 33% upsurge. Additionally, diagnostic testing witnessed considerable action, with 2.2 million tests executed in 2022, presenting a 13% growth in comparison to 2021. Hence, the elevated attention on sexual health will fuel the expansion of the genital herpes market.

What Are The Key Segment Trends Observed In The Genital Herpes Market?

The genital herpesmarket covered in this report is segmented –

1) By Type: Diagnosis; Treatment

2) By Route Of Administration: Oral; Injectable; Topical

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channel

Subsegments:

1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests; Viral Culture Tests; Blood Antibody Tests (Serology); Antigen Detection Tests; Point-Of-Care Rapid Tests

2) By Treatment: Antiviral Medications; Acyclovir; Valacyclovir; Famciclovir; Topical Treatments; Acyclovir Cream; Docosanol Cream; Preventive Therapies; Suppressive Therapy; Prophylactic Vaccines (Under Development); Pain Management Medications; Analgesics; Topical Anesthetics

Which Disruptive Trends Are Driving Change Across The Genital Herpes Market?

Prominent businesses in the genital herpes sector are leveraging strategic alliances to strengthen their technological prowess and extend their market footprint. A strategic alliance usually denotes a cooperative arrangement between two or more entities which pool their resources, skills, and efforts to realize shared aims or objectives. For example, in June 2022, Eurocine Vaccines AB, a biotechnology firm based in Sweden with expertise in the treatment of herpes, rolled out a research and collaboration pact with Redbiotec AG, a biotech firm nestled in Switzerland. This granted them exclusive international rights for the invention, production, and selling of vaccine candidates to combat Herpes Simplex Virus Type 2 (HSV-2). This agreement also includes mRNA- and protein-based methodologies, along with related paperwork and patents within the HSV-2 realm. Eurocine Vaccines has the responsibility to supervise and finance all operations linked to invention, manufacturing and selling until a subsequent licensing transaction with another party is cemented.

Who Are The Leading Companies Driving The Genital Herpes Market?

Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr. Reddy’s Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB, Vical Incorporated

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Which Region Is Forecasted To Lead The Genital Herpes Market In The Coming Years?

North America was the largest region in the genital herpes market in 2024. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17161&type=smp

Browse Through More Reports Similar to the Global Genital Herpes Market 2025, By The Business Research Company

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Cryogenic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Pump Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-pump-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model